Novation

FGIC Announces Entry into Transaction Support Agreement to Pursue a Potential Accelerated Run-Off Transaction

Retrieved on: 
Thursday, February 29, 2024
Professional Services, Public Policy, Government, State, Local, Insurance, Finance, Banking, Financial services, Financial Guaranty Insurance Company, Investment, CPP, CUSIP, Policy, Novation, Rehabilitation, DPO, Negotiation, FGIC, Supreme court, Life insurance

A copy of this Transaction Support Agreement will be posted to FGIC’s website at www.fgic.com/proposedacceleratedrunoff/ .

Key Points: 
  • A copy of this Transaction Support Agreement will be posted to FGIC’s website at www.fgic.com/proposedacceleratedrunoff/ .
  • The total amount of Permitted Policy Distributions net of amounts allocable to FGIC-Owned Instruments is estimated to be about $1.480 billion.
  • A copy of this Novation Agreement will be posted to FGIC’s website at www.fgic.com/proposedacceleratedrunoff/ .
  • The Proposed Transaction will become effective only if, among other things, the required court approvals are obtained.

JASON S. GOLDSTEIN OF PARKER WAICHMAN LLP NAMED TO LEADERSHIP ROLE IN NATIONAL EXACTECH LITIGATION

Retrieved on: 
Friday, December 16, 2022
District court, Hip, PSC, Ankle, Order, Lawyer, Truliant Federal Credit Union, 3rd millennium, Connexion, Court, Plaintiff, Bone loss, Parker, Committee, Novation, MDL, Knee, Woman, Patient, Multimedia, MCS, Inflammation, Osteoporosis, Vantage, Practice of law, Medical device

NEW YORK, Dec. 16, 2022 /PRNewswire/ --Jason S. Goldstein, a senior attorney in the Mass Torts Department for the national law firm Parker Waichman LLP, has been named to the Plaintiff's Steering Committee ("PSC") in the multi-district litigation (MDL) involving certain orthopedic devices manufactured by Exactech.

Key Points: 
  • NEW YORK, Dec. 16, 2022 /PRNewswire/ --Jason S. Goldstein, a senior attorney in the Mass Torts Department for the national law firm Parker Waichman LLP, has been named to the Plaintiff's Steering Committee ("PSC") in the multi-district litigation (MDL) involving certain orthopedic devices manufactured by Exactech.
  • Mr. Goldstein brings to the group not only substantial experience in litigating orthopedic device cases, but also the full firepower of the Parker Waichman firm, long involved in multi-district litigation nationwide.
  • Jerry Parker, the founding partner of the firm, commented that "Jason Goldstein is a talented mass torts attorney who has extensive experience in pharmaceutical and medical device litigation.
  • Parker Waichman LLP represents multiple plaintiffs in the Exactech MDL, and expects that the size and scope of the litigation will continue to increase, as more prosthetic failures become known.

Cincinnati Children's Names Rosland Fisher McLeod Chief Legal Officer

Retrieved on: 
Monday, August 8, 2022
Intellectual property, Multimedia, Southern Methodist University, Pharma, CEO, Senior, Leadership, Biotechnology, University of Houston Law Center, Hospital, National, LLC, Board, Research, McLeod, African Americans, Compliance, Cincinnati Children's Hospital Medical Center, University of Kansas Health System St. Francis Campus, Education, Corporation, Triad Hospitals, View, Public affairs, Child, Biogen, Becker, Methodist University, University, Employment, Trustee, Novation, MD, Hotel manager, Management, Medicine, Rosland Capital, Health

CINCINNATI, Aug. 8, 2022 /PRNewswire/ -- Rosland Fisher McLeod will join Cincinnati Children's as Senior Vice President, Legal and Public Affairs and Chief Legal Officer on September 6, 2022.

Key Points: 
  • Texas native will begin on September 6, 2022
    CINCINNATI, Aug. 8, 2022 /PRNewswire/ -- Rosland Fisher McLeod will join Cincinnati Children's as Senior Vice President, Legal and Public Affairs and Chief Legal Officer on September 6, 2022.
  • As the senior executive for all legal and public affairs at Cincinnati Children's, McLeod will serve as legal advisor to the Executive Team and Board of Trustees.
  • "I am excited to add Rosland to our team," said Steve Davis, MD, President & CEO of Cincinnati Children's.
  • Most recently, she served as Senior Vice President, Chief Legal Officer and Corporate Secretary for SCL Health in Denver, Colorado.

Transaction in Own Shares

Retrieved on: 
Tuesday, July 5, 2022
Market abuse, Novation, Company, European Union (Withdrawal) Act 2018, Shell, Listing Rules, Withdrawal, Online gambling, EU, Brexit

These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.
  • In respect of this arrangement, BNP Paribas Exane will make trading decisions in relation to the Companys securities independently of the Company for a period from 5 May 2022 up to and including 22 July 2022.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by BNP Paribas Exane on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Shell plc: 21380068P1DRHMJ8KU70

Transaction in Own Shares

Retrieved on: 
Monday, July 4, 2022
Market abuse, Novation, Company, European Union (Withdrawal) Act 2018, Shell, Listing Rules, Withdrawal, Online gambling, EU, Brexit

These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.
  • In respect of this arrangement, BNP Paribas Exane will make trading decisions in relation to the Companys securities independently of the Company for a period from 5 May 2022 up to and including 22 July 2022.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by BNP Paribas Exane on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Shell plc: 21380068P1DRHMJ8KU70

Transaction in Own Shares

Retrieved on: 
Friday, July 1, 2022
Market abuse, Novation, Company, European Union (Withdrawal) Act 2018, Shell, Listing Rules, Withdrawal, Online gambling, EU, Brexit

These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.
  • In respect of this arrangement, BNP Paribas Exane will make trading decisions in relation to the Companys securities independently of the Company for a period from 5 May 2022 up to and including 22 July 2022.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by BNP Paribas Exane on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Shell plc: 21380068P1DRHMJ8KU70

Jake Garner Appointed as Northeast US & Canadian Technical Sales Rep for Provident

Retrieved on: 
Thursday, June 30, 2022
Novation, Garner, Northeast U.S. flooding of October 2005, Printing, Growth, Blood, Industry, NE, Provident

APPLETON, Wis., June 30, 2022 /PRNewswire-PRWeb/ -- The appointment of Jake Garner as Northeast U.S. & Canadian Technical Sales Rep for Provident, a leading manufacturer and distributor of pressroom products such as doctor blades, end seals, anilox cleaning products, Troika AniCam, Novation defect flagging systems, and more - is announced by Al Jasper, National Sales Manager for Provident.

Key Points: 
  • Jake Garner has moved over to Provident, a leading manufacturer and distributor of pressroom products, as the new Northeast U.S. & Canadian Technical Sales Representative.
  • APPLETON, Wis., June 30, 2022 /PRNewswire-PRWeb/ -- The appointment of Jake Garner as Northeast U.S. & Canadian Technical Sales Rep for Provident, a leading manufacturer and distributor of pressroom products such as doctor blades, end seals, anilox cleaning products, Troika AniCam, Novation defect flagging systems, and more - is announced by Al Jasper, National Sales Manager for Provident.
  • Garner previously served as an East Coast Account Manager for Anderson & Vreeland, Inc. where he oversaw a territory of six states.
  • "I'm honored to have the opportunity to take on new challenges and drive further growth for Provident," said Garner.

Transaction in Own Shares

Retrieved on: 
Thursday, June 30, 2022
Market abuse, Novation, Company, European Union (Withdrawal) Act 2018, Shell, Listing Rules, Withdrawal, Online gambling, EU, Brexit

These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.
  • In respect of this arrangement, BNP Paribas Exane will make trading decisions in relation to the Companys securities independently of the Company for a period from 5 May 2022 up to and including 22 July 2022.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by BNP Paribas Exane on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Shell plc: 21380068P1DRHMJ8KU70

Transaction in Own Shares

Retrieved on: 
Wednesday, June 29, 2022
Market abuse, Novation, Company, European Union (Withdrawal) Act 2018, Shell, Listing Rules, Withdrawal, Online gambling, EU, Brexit

These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.
  • In respect of this arrangement, BNP Paribas Exane will make trading decisions in relation to the Companys securities independently of the Company for a period from 5 May 2022 up to and including 22 July 2022.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by BNP Paribas Exane on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Shell plc: 21380068P1DRHMJ8KU70

Transaction in Own Shares

Retrieved on: 
Tuesday, June 28, 2022
Market abuse, Novation, Company, European Union (Withdrawal) Act 2018, Shell, Listing Rules, Withdrawal, Online gambling, EU, Brexit

These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.

Key Points: 
  • These share purchases form part of the Company's share buy-back arrangement previously announced on 5 May 2022.
  • In respect of this arrangement, BNP Paribas Exane will make trading decisions in relation to the Companys securities independently of the Company for a period from 5 May 2022 up to and including 22 July 2022.
  • In accordance with EU MAR and UK MAR, a full breakdown of the individual trades made by BNP Paribas Exane on behalf of the Company as a part of the buy-back arrangement is detailed below.
  • LEI number of Shell plc: 21380068P1DRHMJ8KU70